Open AccessDipeptidyl-peptidase-4 inhibitors in type 2 diabetes and COVID-19: From a potential repurposed agent to a useful treatment option
Author(s) -
Awadhesh Kumar Singh,
Ritu Singh
Publication year - 2020
Publication title -
journal of diabetology
Language(s) - English
Resource type - Journals
eISSN - 2543-3288
pISSN - 2078-7685
DOI - 10.4103/jod.jod_53_20
Subject(s) - dipeptidyl peptidase 4 , type 2 diabetes , diabetes mellitus , medicine , hypoglycemia , covid-19 , coronavirus , vildagliptin , type 1 diabetes , pharmacology , intensive care medicine , disease , endocrinology , infectious disease (medical specialty)